Dice Therapeutics Inc DICE

$25.16 -22.39 (-47.08%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
600
Avg volume
—
Day's range
$25.16 – $25.69
Shares out
—
Stochastic %K
—
Beta
—
Analysts
Sell
Price target
$53.73

Price

Company profile

Under normal circumstances seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in domestic and foreign, common and preferred stocks of publicly listed companies that the Adviser determines are Trading and Prediction Markets Companies. The fund is non-diversified.

Latest news

No headlines yet.